plicamycin has been researched along with Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoyama, T; Furu, M; Kajita, Y; Katagiri, T; Kato, T; Nagayama, S; Nakamura, E; Nakamura, Y; Nishiyama, H; Ogawa, O; Takahashi, R; Tamaki, S; Toguchida, J | 1 |
1 other study(ies) available for plicamycin and Sarcoma
Article | Year |
---|---|
The transcription factor Sp3 regulates the expression of a metastasis-related marker of sarcoma, actin filament-associated protein 1-like 1 (AFAP1L1).
Topics: Adaptor Proteins, Signal Transducing; Binding Sites; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Luciferases; Microfilament Proteins; Neoplasm Metastasis; Plicamycin; Promoter Regions, Genetic; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sarcoma; Sp3 Transcription Factor; Transcriptional Activation | 2013 |